These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Using the 4 Pillars™ Practice Transformation Program to increase adolescent human papillomavirus, meningococcal, tetanus-diphtheria-pertussis and influenza vaccination. Zimmerman RK; Raviotta JM; Nowalk MP; Moehling KK; Reis EC; Humiston SG; Lin CJ Vaccine; 2017 Oct; 35(45):6180-6186. PubMed ID: 28947346 [TBL] [Abstract][Full Text] [Related]
5. Overcoming barriers to adolescent vaccination: perspectives from vaccine providers in North Carolina. Vielot NA; Islam JY; Sanusi B; Myers J; Smith S; Meadows B; Brewer NT; Smith JS Women Health; 2020; 60(10):1129-1140. PubMed ID: 32772834 [TBL] [Abstract][Full Text] [Related]
6. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). Broder KR; Cortese MM; Iskander JK; Kretsinger K; Slade BA; Brown KH; Mijalski CM; Tiwari T; Weston EJ; Cohn AC; Srivastava PU; Moran JS; Schwartz B; Murphy TV; MMWR Recomm Rep; 2006 Mar; 55(RR-3):1-34. PubMed ID: 16557217 [TBL] [Abstract][Full Text] [Related]
7. Adolescent Vaccination Performance in South Carolina Compared to the United States. Roberts JR; Naifeh M; Jacobson RM; Hinton E; O'Brien E; Rogacki B; Thompson D; Margolis B; Darden PM J S C Med Assoc; 2015 Dec-2016 Jan; 111(4):117-21. PubMed ID: 27141702 [TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus vaccination at the first opportunity: An overview. Bednarczyk RA; Brewer NT; Gilkey MB; Zorn S; Perkins RB; Oliver K; Saslow D Hum Vaccin Immunother; 2023 Dec; 19(1):2213603. PubMed ID: 37218520 [TBL] [Abstract][Full Text] [Related]
9. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2017. Walker TY; Elam-Evans LD; Yankey D; Markowitz LE; Williams CL; Mbaeyi SA; Fredua B; Stokley S MMWR Morb Mortal Wkly Rep; 2018 Aug; 67(33):909-917. PubMed ID: 30138305 [TBL] [Abstract][Full Text] [Related]
10. Descriptive epidemiology of age at HPV vaccination: Analysis using the 2020 NIS-Teen. Bednarczyk RA; Brandt HM Hum Vaccin Immunother; 2023 Dec; 19(1):2204784. PubMed ID: 37138466 [TBL] [Abstract][Full Text] [Related]
11. Missed opportunities for adolescent vaccination, 2006-2011. Wong CA; Taylor JA; Wright JA; Opel DJ; Katzenellenbogen RA J Adolesc Health; 2013 Oct; 53(4):492-7. PubMed ID: 23809613 [TBL] [Abstract][Full Text] [Related]
12. MenACWY-TT is immunogenic when co-administered with Tdap and AS04-HPV16/18 in girls and young women: Results from a phase III randomized trial. Rivera L; Chanthavanich P; Põder A; Suryakiran PV; Jastorff A; Van der Wielen M Vaccine; 2018 Jun; 36(27):3967-3975. PubMed ID: 29789243 [TBL] [Abstract][Full Text] [Related]
14. Effect of Hurricane Maria on HPV, Tdap, and meningococcal conjugate vaccination rates in Puerto Rico, 2015-2019. Colón-López V; Díaz-Miranda OL; Medina-Laabes DT; Soto-Abreu R; Vega-Jimenez I; Ortiz AP; Suárez EL Hum Vaccin Immunother; 2021 Dec; 17(12):5623-5627. PubMed ID: 34856874 [TBL] [Abstract][Full Text] [Related]
15. Patterns of Use of Human Papillomavirus and Other Adolescent Vaccines in the United States. Vielot NA; Butler AM; Brookhart MA; Becker-Dreps S; Smith JS J Adolesc Health; 2017 Sep; 61(3):281-287. PubMed ID: 28739327 [TBL] [Abstract][Full Text] [Related]
16. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2019. Elam-Evans LD; Yankey D; Singleton JA; Sterrett N; Markowitz LE; Williams CL; Fredua B; McNamara L; Stokley S MMWR Morb Mortal Wkly Rep; 2020 Aug; 69(33):1109-1116. PubMed ID: 32817598 [TBL] [Abstract][Full Text] [Related]
17. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2020. Pingali C; Yankey D; Elam-Evans LD; Markowitz LE; Williams CL; Fredua B; McNamara LA; Stokley S; Singleton JA MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(35):1183-1190. PubMed ID: 34473682 [TBL] [Abstract][Full Text] [Related]
18. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. America Academy of Pediatrics Commitee on Infectious Diseases Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131 [TBL] [Abstract][Full Text] [Related]
19. National and state vaccination coverage among adolescents aged 13-17 years--United States, 2012. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2013 Aug; 62(34):685-93. PubMed ID: 23985496 [TBL] [Abstract][Full Text] [Related]
20. Missed Opportunities for Adolescent Immunizations at Well-Care Visits During the COVID-19 Pandemic. Kelly MK; Stephens-Shields AJ; Hannan C; Rand CM; Localio R; Shone LP; Steffes J; Davis K; Grundmeier RW; Humiston SG; Albertin C; McFarland G; Abney DE; Szilagyi PG; Fiks AG J Adolesc Health; 2023 Sep; 73(3):595-598. PubMed ID: 37389529 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]